Results 1 to 10 of about 37,942 (184)

PROGNOSTICATION OF VACCINATION EFFICACY

Педиатрическая фармакология, 2010
The article focuses on the study of protective immunity in vaccination with pneumococcal conjugated 7-valent vaccine (PCV7) against related vaccine serotypes.
N.F. Snegova, S.M. Kharit, V.K. Tatochenko, M.P. Kostinov   +3 more
doaj   +2 more sources

Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study

BMC Infectious Diseases, 2007
Background Polysaccharide pneumococcal vaccine is recommended for use in HIV-infected adults in Brazil but there is uncertainty about its effectiveness in this patient population. The main objective of this study was to assess the effectiveness of the 23-
Veras Maria, Enanoria Wayne TA, Castilho Euclides A, Reingold Arthur L   +3 more
doaj   +1 more source

30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization [PDF]

, 2022
Tianjing Hu, David F. Miller, Amber W. Taylor, Christine M. Riley, Caitlin McCormick, Keely N. Thomas, Rachel Y. Gao, Kathy L. Rowlen, Emilia B. Byrne, Pardeep Kumar, Soo Kyung Kim, Erica L. Dawson   +11 more
openalex   +1 more source

Global Coverage of Pneumococcal Conjugate Vaccine (PCV) and Serotype Distribution after Receiving Vaccine among Targeted PCV Vaccine Countries: A Systematic Review

مجله اپیدمیولوژی ایران, 2020
Background and Objectives: After the introduction of the pneumococcal vaccine, an increase has been observed in the disease due to nonspecific stereotypes of the vaccine.
S Rahmani, m Karami, , M Adabi, A Doosti Irani   +4 more
doaj  

1106Modeling of nasopharyngeal acquisition as a function of anti-capsular serum antibody concentrations and of ethnicity after vaccination with pneumococcal conjugate vaccines (PCVs) [PDF]

, 2014
Ron Dagan, Christine Juergens, James Trammel, Scott D. Patterson, David Greenberg, Noga Givon‐Lavi, Nurith Porat, William C. Gruber, Daniel A. Scott   +8 more
openalex   +1 more source

Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years

, 2022
Gurunadh R. Chichili, Ronald Smulders, Vicki Santos, Beth Cywin, Laura Kovanda, Charles Van Sant, Frank Malinoski, Shite Sebastian, George R. Siber, Richard Malley   +9 more
openalex   +1 more source

1718. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: an indirect cohort study [PDF]

, 2023
Kristin L. Andrejko, Ryan Gierke, Jemma V. Rowlands, Jennifer B. Rosen, Ann Thomas, Zachary Landis, María Rosales, Susan Petit, William Schaffner, Corinne Holtzman, Monica M. Farley, Meghan Barnes, Lee H. Harrison, Lesley McGee, Sopio Chochua, Jennifer R. Verani, Adam L. Cohen, Tamara Pilishvili, Miwako Kobyashi   +18 more
openalex   +1 more source

Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine [PDF]

, 2017
Joon Kee Lee, Song I Yang, Sun Hyoung Park, Ki Wook Yoon, Hyunju Lee, Eun Hwa Choi, Hoan Jong Lee   +6 more
openalex   +1 more source

Influence of Older Age and Other Risk Factors on Pneumonia Hospitalization in Switzerland in the Pneumococcal Vaccine Era

Frontiers in Medicine, 2019
Background: Pneumococcal pneumonia is a disease of the extremes of age. However, as other traditional risk factors for pneumococcal pneumonia also increase with older age, it is unclear if older age itself should be an indication for pneumococcal ...
Werner C. Albrich, Frank Rassouli, Frederike Waldeck, Christoph Berger, Florent Baty   +4 more
doaj   +1 more source

Hematological parameters in dry cows after immunization with a polyvalent pneumococcal vaccine

, 2021
Oleg Yu. Chernykh, V.V. Chekrysheva, Anna Shevchenko, П.А. Красочко, A.M. Misnik   +4 more
openalex   +1 more source